We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

80 hedge funds and large institutions have $189M invested in BioSpecifics Technologies Corp. in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

50% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 26

3% more funds holding

Funds holding: 78 → 80 (+2)

2% more capital invested

Capital invested by funds: $185M → $189M (+$4.09M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
39
Reduced
26
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.53M
2
TAM
THB Asset Management
Connecticut
+$2.91M
3
RHJA
Rice Hall James & Associates
California
+$1.82M
4
AL
AJO LP
Pennsylvania
+$1.14M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$5.54M
2
EAM
Eagle Asset Management
Florida
-$2.37M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.74M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$631K
5
SGI
Summit Global Investments
Utah
-$616K
Name Holding Trade Value Shares
Change 		Change in
Stake
First Manhattan
26
First Manhattan
New York
$1.77M +$559K +13,000 +49%
OAM
27
Oxford Asset Management
United Kingdom
$1.74M -$137K -3,193 -8%
TCIM
28
TIAA CREF Investment Management
New York
$1.61M +$151K +3,502 +11%
Millennium Management
29
Millennium Management
New York
$1.58M +$456K +10,601 +43%
Man Group
30
Man Group
United Kingdom
$1.5M -$175K -4,060 -11%
CAM
31
ClariVest Asset Management
California
$1.39M -$26.1K -607 -2%
Russell Investments Group
32
Russell Investments Group
United Kingdom
$1.16M +$696K +16,177 +166%
Morgan Stanley
33
Morgan Stanley
New York
$1.1M -$98.5K -2,291 -9%
Invesco
34
Invesco
Georgia
$1.05M +$99.8K +2,320 +11%
MCM
35
Matarin Capital Management
New York
$913K -$577K -13,422 -40%
IP
36
Isthmus Partners
Wisconsin
$867K +$31.7K +738 +4%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$814K +$59.4K +1,382 +8%
Two Sigma Investments
38
Two Sigma Investments
New York
$746K -$57.7K -1,341 -7%
SCA
39
Secor Capital Advisors
New York
$592K -$163K -3,780 -22%
SO
40
STRS Ohio
Ohio
$583K – – –
Two Sigma Advisers
41
Two Sigma Advisers
New York
$579K -$108K -2,500 -16%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$565K +$93.1K +2,165 +21%
PPA
43
Parametric Portfolio Associates
Washington
$537K +$113K +2,633 +28%
American Century Companies
44
American Century Companies
Missouri
$453K -$48K -1,115 -10%
TA
45
Teachers Advisors
New York
$453K – – –
GCP
46
GSA Capital Partners
United Kingdom
$426K +$193K +4,491 +90%
CIBC Private Wealth Group
47
CIBC Private Wealth Group
Georgia
$414K -$48.8K -1,135 -11%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$391K +$4.34K +101 +1%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$296K -$42.9K -997 -13%
SGAM
50
Smith Group Asset Management
Texas
$276K +$1.16K +27 +0.4%
1
2
3 4

BSTC Hedge Fund Activity: Q2 2018 in Review

80 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2018, worth a combined $189M — up 2.2% from $185M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BSTC positions and 4 closed out — a net gain of 2 holders — while 39 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $3.53M. The largest seller was Stonepine Capital Management, cutting an estimated $5.54M.

  • 80 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2018, up from 78 in Q1 2018.
  • Funds reported $189M of BioSpecifics Technologies Corp. stock for Q2 2018, up 2.2% quarter-over-quarter.
  • 6 funds opened new BioSpecifics Technologies Corp. positions in Q2 2018 and 4 closed out, a net change of +2 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2018 was BlackRock, an estimated $3.53M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2018 was Stonepine Capital Management, an estimated $5.54M sold.

Based on aggregated 13F filings for Q2 2018.